{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:00:29Z","timestamp":1791219629850,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"978","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>People with type 1 diabetes have normal exocrine pancreatic function, making islet cell rather than whole organ transplantation an attractive option. Achieving insulin independence in type 1 diabetes was the perceived goal of islet cell transplantation. The success of the Edmonton group in achieving this in a selected group of type 1 patients has led to renewed optimism that this treatment could eventually replace whole organ pancreas transplantation. However the long-term results of this treatment indicate that insulin independence is lost with time in a significant proportion of patients, although they may retain glycaemic stability. In this context, the indications for islet cell transplantation, which have evolved over the last 5 years, indicate that the patients who benefit most are those who experience severe hypoglycaemic reactions despite optimal insulin therapy. This review will summarise the history of islet cell transplantation, islet isolation techniques, the transplant procedure, immunosuppressive therapy, indications for islet cell transplantation, current clinical trials, the early UK islet cell transplant experience using the Edmonton protocol, and some of the challenges that lie ahead.<\/jats:p>","DOI":"10.1136\/pgmj.2006.053447","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T17:58:50Z","timestamp":1175536730000},"page":"224-229","source":"Crossref","is-referenced-by-count":45,"title":["Islet cell transplantation"],"prefix":"10.1093","volume":"83","author":[{"given":"P","family":"Srinivasan","sequence":"first","affiliation":[{"name":"King's College London School of Medicine at King's College Hospital, Institute of Liver Studies and Diabetes Research Group, King's College Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G C","family":"Huang","sequence":"additional","affiliation":[{"name":"King's College London School of Medicine at King's College Hospital, Institute of Liver Studies and Diabetes Research Group, King's College Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Amiel","sequence":"additional","affiliation":[{"name":"King's College London School of Medicine at King's College Hospital, Institute of Liver Studies and Diabetes Research Group, King's College Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N D","family":"Heaton","sequence":"additional","affiliation":[{"name":"King's College London School of Medicine at King's College Hospital, Institute of Liver Studies and Diabetes Research Group, King's College Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,4,2]]},"reference":[{"key":"2023042013000037000_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Eng J Med"},{"key":"2023042013000037000_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2337\/diacare.23.1.117","article-title":"Pancreas transplantation for patients with type 1 diabetes: American Diabetes Association","volume":"23","author":"American Diabetes Association","year":"2000","journal-title":"Diabetes Care"},{"key":"2023042013000037000_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.26.2007.S120","article-title":"Pancreas transplantation for patients with type 1 diabetes: American Diabetes Association","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care"},{"key":"2023042013000037000_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in 7 patients with type1 diabetes mellitus using a glucocorticoid-free immunosuppression regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"2023042013000037000_bib5","first-page":"2054","article-title":"Edmonton's islet success tough to duplicate elsewhere","volume":"361","author":"Ault","year":"2003","journal-title":"Lancet"},{"key":"2023042013000037000_bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(03)14526-6","article-title":"Edmonton's islet success has indeed been replicated elsewhere","volume":"9391","author":"Shapiro","year":"2003","journal-title":"Lancet"},{"key":"2023042013000037000_bib7","first-page":"175","article-title":"Transplantation of intact pancreatic islets in rats","volume":"72","author":"Ballinger","year":"1972","journal-title":"Surgery"},{"key":"2023042013000037000_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00000658-198010000-00011","article-title":"Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis","volume":"192","author":"Najarian","year":"1980","journal-title":"Ann Surg"},{"key":"2023042013000037000_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJM199207233270402","article-title":"Preserved insulin secretion and insulin independence in recipients of islet autografts","volume":"327","author":"Pyzdrowski","year":"1992","journal-title":"N Engl J Med"},{"key":"2023042013000037000_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00007890-198001000-00017","article-title":"A long-term functioning human pancreatic islet allotransplant","volume":"29","author":"Largiader","year":"1980","journal-title":"Transplantation"},{"key":"2023042013000037000_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2337\/diabetes.53.4.955","article-title":"Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation","volume":"53","author":"Ryan","year":"2004","journal-title":"Diabetes"},{"key":"2023042013000037000_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1464-5491.2005.01539.x","article-title":"Indications and efficacy of continuous subcutaneous insulin infusion (CS11) therapy in type 1 diabetes mellitus: a clinical audit in a specialist service","volume":"22","author":"Rodrigues","year":"2005","journal-title":"Diabetic Medicine"},{"key":"2023042013000037000_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/bmj.322.7290.861","article-title":"Could fewer islet cells be transplanted in type 1 diabetes? Insulin independence should be dominant force in islet transplantation","volume":"322","author":"Shapiro","year":"2001","journal-title":"BMJ"},{"key":"2023042013000037000_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/diabetes.50.4.710","article-title":"Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol","volume":"50","author":"Ryan","year":"2001","journal-title":"Diabetes"},{"key":"2023042013000037000_bib15","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/diabetes.51.7.2148","article-title":"Continued insulin reserve provides long-term glycemic control","volume":"51","author":"Ryan","year":"2002","journal-title":"Diabetes"},{"key":"2023042013000037000_bib16","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"2023042013000037000_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2337\/diab.40.6.680","article-title":"Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control","volume":"40","author":"Clarke","year":"1991","journal-title":"Diabetes"},{"key":"2023042013000037000_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.tp.0000172216.47547.d5","article-title":"The standardization of pancreatic donors for islet isolations","volume":"80","author":"O'Gorman","year":"2005","journal-title":"Transplantation"},{"key":"2023042013000037000_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0029-1211388","article-title":"Body mass index of pancreatic donors: a decisive factor for human islet isolation","volume":"103","author":"Brandhorst","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2023042013000037000_bib20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007890-199604150-00010","article-title":"Variables in organ donors that affect the recovery of human islets of Langerhans","volume":"61","author":"Lakey","year":"1996","journal-title":"Transplantation"},{"key":"2023042013000037000_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/152692480501500205","article-title":"Donor care before pancreatic tissue transplantation","volume":"15","author":"Powner","year":"2005","journal-title":"Prod Trans"},{"key":"2023042013000037000_bib22","first-page":"81","article-title":"Procurement of the human pancreas for pancreatic islet transplantation","volume":"15","author":"Lee","year":"2004","journal-title":"Transplantation"},{"key":"2023042013000037000_bib23","first-page":"1717","volume-title":"Textbook of endocrinology","author":"Evans"},{"key":"2023042013000037000_bib24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1007\/s00125-004-1513-5","article-title":"The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia","volume":"47","author":"Smith","year":"2004","journal-title":"Diabetologia"},{"key":"2023042013000037000_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00534-005-0978-z","article-title":"Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs)","volume":"12","author":"Matsumoto","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"2023042013000037000_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TP.0000130177.03326.D5","article-title":"Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation","volume":"78","author":"Matsumoto","year":"2004","journal-title":"Transplantation"},{"key":"2023042013000037000_bib27","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(05)66383-0","article-title":"Insulin independence after living-donor distal pancreatectomy and islet allotransplantation","volume":"365","author":"Matsumoto","year":"2005","journal-title":"Lancet"},{"key":"2023042013000037000_bib28","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(05)66382-9","article-title":"Live organ-donation for islet transplantation","volume":"365","author":"Amiel","year":"2005","journal-title":"Lancet"},{"key":"2023042013000037000_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.TP.0000133515.37892.D5","article-title":"Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method","volume":"78","author":"Tsujimura","year":"2004","journal-title":"Transplantation"},{"key":"2023042013000037000_bib30","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1600-6143.2005.00957.x","article-title":"Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience","volume":"5","author":"Froud","year":"2005","journal-title":"Am J Transplant"},{"key":"2023042013000037000_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/03009734000000059","article-title":"Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes","volume":"105","author":"Bennet","year":"2000","journal-title":"Ups J Med Sci"},{"key":"2023042013000037000_bib32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/01.tp.0000187881.97068.77","article-title":"Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation","volume":"80","author":"Hafiz","year":"2005","journal-title":"Transplantation"},{"key":"2023042013000037000_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/01.TP.0000128332.71657.EA","article-title":"Portal vein thrombosis complicating islet transplantation in a recipient with the factor V Leiden mutation","volume":"78","author":"Brennan","year":"2004","journal-title":"Transplantation"},{"key":"2023042013000037000_bib34","first-page":"1290","article-title":"New technique improves safety of islet cell transplantation","volume":"331","author":"Hopkins Tanne","year":"2005","journal-title":"BMJ"},{"key":"2023042013000037000_bib35","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"2023042013000037000_bib36","volume":"49","author":"Gerber","year":"2006","journal-title":"Which to prefer: simultaneous islet-kidney or pancreas-kidney transplantation in type1 diabetes mellitus: a six year single center follow-up. Diabetologia"},{"key":"2023042013000037000_bib37","first-page":"631","volume":"240","author":"Frank","journal-title":"Transplantation for type i diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets"},{"key":"2023042013000037000_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jama.293.7.830","article-title":"Single-donor, marginal-dose islet transplantation in patients with type 1diabetes","volume":"293","author":"Hering","year":"2005","journal-title":"JAMA"},{"key":"2023042013000037000_bib39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI200423235","article-title":"Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus","volume":"114","author":"Rother","year":"2004","journal-title":"J Clin Invest"},{"key":"2023042013000037000_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.306.5693.34","article-title":"Diabetes. Islet transplants face test of time","volume":"306","author":"Couzin","year":"2004","journal-title":"Science"},{"key":"2023042013000037000_bib41","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/00007890-200106270-00002","article-title":"Novel approaches toward early diagnosis of islet allograft rejection","volume":"71","author":"Shapiro","year":"2001","journal-title":"Transplantation"},{"key":"2023042013000037000_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2337\/diacare.28.2.343","article-title":"Beta-score: An assessment of beta-cell function after islet transplantation","volume":"28","author":"Ryan","year":"2005","journal-title":"Diabetes Care"},{"key":"2023042013000037000_bib43","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.TP.0000157300.53976.2A","article-title":"Strategic opportunities in clinical islet transplantation","volume":"79","author":"Shapiro","year":"2005","journal-title":"Transplantation"},{"key":"2023042013000037000_bib44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1600-6135.2003.0154.x","article-title":"Clinical trials of transplant tolerance: slow but steady progress","volume":"3","author":"Matthews","year":"2003","journal-title":"Am J Transplant"},{"key":"2023042013000037000_bib45","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/ten.2005.11.1323","article-title":"Development of an ectopic site for islet transplantation, using biodegradable scaffolds","volume":"11","author":"Dufour","year":"2005","journal-title":"Tissue Eng"},{"key":"2023042013000037000_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-6143.2005.01157.x","article-title":"Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning","volume":"6","author":"Yin","year":"2006","journal-title":"Am J Transplant"},{"key":"2023042013000037000_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1432-2277.2006.00343.x","article-title":"The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation","volume":"19","author":"Magliocca","year":"2006","journal-title":"Transpl Int"},{"key":"2023042013000037000_bib48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1432-2277.2005.00144.x","article-title":"Current practices of donor pancreas allocation in the UK: future implications for pancreas and islet transplantation","volume":"18","author":"Ridgway","year":"2005","journal-title":"Transpl Int"},{"key":"2023042013000037000_bib49","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.surg.2005.02.007","article-title":"Hepatic regeneration promotes engraftment of intraportally transplanted islet cells","volume":"137","author":"Sudo","year":"2005","journal-title":"Surgery"},{"key":"2023042013000037000_bib50","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.53.12.3107","article-title":"Islet graft assessment in the Edmonton protocol: implications for predicting long-term clinical outcome","volume":"53","author":"Street","year":"2004","journal-title":"Diabetes"},{"key":"2023042013000037000_bib51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.293.7.830","article-title":"Single-donor, marginal-dose islet transplantation in patients with type1 diabetes","volume":"293","author":"Hering","year":"2005","journal-title":"JAMA"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/83\/978\/224\/50023106\/postgradmedj-83-224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/83\/978\/224\/50023106\/postgradmedj-83-224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:56:04Z","timestamp":1682002564000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/83\/978\/224\/7045338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":51,"journal-issue":{"issue":"978","published-online":{"date-parts":[[2007,4,2]]},"published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2006.053447","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,4]]},"published":{"date-parts":[[2007,4,1]]}}}